Your browser doesn't support javascript.
loading
Population-level deficit of homozygosity unveils CPSF3 as an intellectual disability syndrome gene.
Arnadottir, Gudny A; Oddsson, Asmundur; Jensson, Brynjar O; Gisladottir, Svanborg; Simon, Mariella T; Arnthorsson, Asgeir O; Katrinardottir, Hildigunnur; Fridriksdottir, Run; Ivarsdottir, Erna V; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Barrick, Rebekah; Saemundsdottir, Jona; le Roux, Louise; Oskarsson, Gudjon R; Asmundsson, Jurate; Steffensen, Thora; Gudmundsson, Kjartan R; Ludvigsson, Petur; Jonsson, Jon J; Masson, Gisli; Jonsdottir, Ingileif; Holm, Hilma; Jonasson, Jon G; Magnusson, Olafur Th; Thorarensen, Olafur; Abdenur, Jose; Norddahl, Gudmundur L; Gudbjartsson, Daniel F; Bjornsson, Hans T; Thorsteinsdottir, Unnur; Sulem, Patrick; Stefansson, Kari.
Afiliação
  • Arnadottir GA; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Oddsson A; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Jensson BO; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Gisladottir S; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Simon MT; Department of Genetics and Molecular Medicine, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Arnthorsson AO; Division of Metabolic Disorders, Children's Hospital of Orange County, Orange, CA, USA.
  • Katrinardottir H; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Fridriksdottir R; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Ivarsdottir EV; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Jonasdottir A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Jonasdottir A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Barrick R; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Saemundsdottir J; Division of Metabolic Disorders, Children's Hospital of Orange County, Orange, CA, USA.
  • le Roux L; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Oskarsson GR; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Asmundsson J; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Steffensen T; Department of Pathology, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Gudmundsson KR; Department of Pathology, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Ludvigsson P; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Jonsson JJ; Children's Hospital Iceland, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Masson G; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Jonsdottir I; Department of Genetics and Molecular Medicine, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Holm H; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Jonasson JG; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Magnusson OT; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Thorarensen O; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Abdenur J; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Norddahl GL; Department of Pathology, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Gudbjartsson DF; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Bjornsson HT; Children's Hospital Iceland, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Thorsteinsdottir U; Division of Metabolic Disorders, Children's Hospital of Orange County, Orange, CA, USA.
  • Sulem P; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Stefansson K; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Nat Commun ; 13(1): 705, 2022 02 04.
Article em En | MEDLINE | ID: mdl-35121750
ABSTRACT
Predicting the pathogenicity of biallelic missense variants can be challenging. Here, we use a deficit of observed homozygous carriers of missense variants, versus an expected number in a set of 153,054 chip-genotyped Icelanders, to identify potentially pathogenic genotypes. We follow three missense variants with a complete deficit of homozygosity and find that their pathogenic effect in homozygous state ranges from severe childhood disease to early embryonic lethality. One of these variants is in CPSF3, a gene not previously linked to disease. From a set of clinically sequenced Icelanders, and by sequencing archival samples targeted through the Icelandic genealogy, we find four homozygous carriers. Additionally, we find two homozygous carriers of Mexican descent of another missense variant in CPSF3. All six homozygous carriers of missense variants in CPSF3 show severe intellectual disability, seizures, microcephaly, and abnormal muscle tone. Here, we show how the absence of certain homozygous genotypes from a large population set can elucidate causes of previously unexplained recessive diseases and early miscarriage.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Mutação de Sentido Incorreto / Fator de Especificidade de Clivagem e Poliadenilação / Homozigoto / Deficiência Intelectual Tipo de estudo: Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Mutação de Sentido Incorreto / Fator de Especificidade de Clivagem e Poliadenilação / Homozigoto / Deficiência Intelectual Tipo de estudo: Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article